Heinrich Bodenstein
Heinrich Bodenstein publishes mostly in Hematology, Oncology and Genetics, on topics such as Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and Chronic Lymphocytic Leukemia Research.
- World rank
- #1,081,202 of 7,710,434 ranked researchers
- Rank in Germany
- #53,182 of 364,343
- Works
- 70
- Citations
- 3.4k
- Citations per work
- 48.1
What does Heinrich Bodenstein research?
Heinrich Bodenstein's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4056.8%
- Medicine4056.8%
- Everything else2535.3%
- Life Sciences67.9%
- 1Hematology27% of their works
- 2Oncology10% of their works
- 3Genetics8% of their works
- 4Molecular Biology8% of their works
- 5Pulmonary and Respiratory Medicine6% of their works
- 6Public Health, Environmental and Occupational Health6% of their works
Research topics
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Retinoids in leukemia and cellular processes
Which keywords describe Heinrich Bodenstein's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Minimal Residual Disease, Rituximab, Acute Lymphoblastic Leukemia, Childhood Cancer and Chronic Lymphocytic Leukemia.
- Acute Promyelocytic Leukemia
- JAK2 Mutation
- Imatinib
- BCR-ABL
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Acute Lymphoblastic Leukemia
- Minimal Residual Disease
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Rituximab
- Childhood Cancer
- Classification
- Lymphoma
- Diagnosis Criteria
- International Myeloma Working Group
- Myelofibrosis
- Retinoic Acid
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors433 topics
- AML261 topic
- Acute Myeloid Leukemia261 topic
- Minimal Residual Disease162 topics
- Rituximab162 topics
- Acute Lymphoblastic Leukemia91 topic
- Childhood Cancer91 topic
- Chronic Lymphocytic Leukemia81 topic
- Classification81 topic
- Genomic Aberrations81 topic
- Lymphoma81 topic
- BCR-ABL71 topic
- Diagnosis Criteria71 topic
- Imatinib71 topic
- International Myeloma Working Group71 topic
- JAK2 Mutation71 topic
- Myelofibrosis71 topic
- Acute Promyelocytic Leukemia61 topic
- Retinoic Acid61 topic
Where does Heinrich Bodenstein work?
Heinrich Bodenstein's main affiliation in the publication record is Johannes Wesling Klinikum Minden, Germany.
How many publications and citations does Heinrich Bodenstein have?
OpenAlex counts 70 works and 3,370 citations for Heinrich Bodenstein, an h-index of 20, ranking #1,081,202 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Heinrich Bodenstein. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.